Most recently, it has been discovered that conolidine and the above derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in comparable regions as classical opioid receptors, it binds to some wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts as being a scavenger https://brianm516fwm1.blogspothub.com/profile